Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,177 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04111978RecruitingPhase 3
Maintenance hormone therapy after ovarian cancer responds
This Phase 3 trial tests whether ongoing treatment with an aromatase inhibitor (a hormone-blocking medicine) after initial chemotherapy can help keep epithelial ovarian/fallopian tube/peritoneal cancer from coming back. It is only for certain tumor types that are hormone-receptor positive (ER+).
GrazAges 18 years+ - NCT05068674RecruitingPhase 1
Stem cell heart muscle therapy for weak heart after prior heart attack
This Phase 1 study tests a treatment made from stem cells to grow heart muscle cells (“cardiomyocytes”) for people with long-lasting (chronic) heart weakness after a prior heart attack. It aims to see if the therapy can improve heart function and is safe in carefully selected patients.
Palo Alto, CaliforniaAges 21–80 - NCT05805202Recruiting
Study rare gene changes in atypical HUS for tailored care
This study looks at how rare gene mutations may explain atypical HUS (aHUS) and how that could guide more personalized treatment. It mainly involves people who have had aHUS affecting blood counts and kidneys.
Ranica, BGAges Any age - NCT05866003Recruiting
Brain stimulation plus hand training after stroke
This trial tests whether a combination of brain stimulation and structured hand practice can improve hand movement for people recovering from stroke. It may help because the training targets upper-limb function while using therapy intended to support recovery.
Cleveland, OhioAges 21–90 - NCT06264531RecruitingPhase 2/Phase 3
Bevacizumab for adults with symptomatic, untreatable brain AVMs
This trial tests a medication called bevacizumab (given as an IV infusion) to see if it can improve symptoms in people with brain arteriovenous malformations (AVMs) that cannot be treated with standard therapies. It is for those whose AVMs cause significant disability.
Paris, Île-de-France RegionAges 18 years+ - NCT06264167Recruiting
Ultrasound for groin lymph nodes in vulvar cancer
This trial tests whether using ultrasound of the groin can help find cancer spread in the lymph nodes of women with early-stage vulvar cancer. The goal is to see if ultrasound can replace or reduce the need for more invasive surgery.
Brisbane, QueenslandAges 18 years+ - NCT06266364Recruiting
Vagus nerve stimulation for treatment-resistant PTSD
This study tests if stimulating the vagus nerve with an implanted device can help adults with chronic PTSD who haven't gotten better with standard treatments. You would have the device implanted and then follow the study plan for several months.
Austin, TexasAges 22–79 - NCT06274047RecruitingPhase 3
Hormone Therapy Timing for Prostate Cancer After Surgery
This trial compares two ways of giving hormone therapy (apalutamide) along with radiation after prostate removal surgery. It aims to see which approach helps maintain quality of life while controlling cancer.
Gilbert, ArizonaAges 18 years+ - NCT06273982Enrolling by invitation
Telehealth for anxiety and depression in youth
This study tests whether a behavioral telehealth program can help teens and children with anxiety or depression. It is designed for patients in community health centers and includes support from a parent or guardian.
Portland, OregonAges 8–16 - NCT06267365Recruiting
Predicting treatment success for chronic pancreatitis
This study looks at whether brain patterns can predict how well endoscopic therapy works for chronic pancreatitis pain. If you have confirmed chronic pancreatitis with blockage in your pancreatic duct and frequent pain, you may be able to join.
New York, New YorkAges 18 years+ - NCT06254794Recruiting
Blood flow restriction rehab after Achilles tendon repair
This study tests whether adding blood flow restriction (BFR) to standard physical therapy helps people recover better after Achilles tendon repair surgery. You may be a good fit if you had a PARS or open repair and plan to rehab at a Methodist Hospital.
Houston, TexasAges 18 years+ - NCT06263712Recruiting
Can brief therapy after a suicide attempt help?
This study tests whether a short therapy program (ASSIP) can help reduce suicide risk by looking at how people think and feel after a suicide attempt. It may be a good fit if you've had a past attempt and are open to a brief, focused therapy.
BernAges 18 years+ - NCT06270251Recruiting
Modeling tic changes during behavior therapy
This study looks at how tics change during a type of behavior therapy for tics. It may help teens and young adults better understand what happens during treatment.
Minneapolis, MinnesotaAges 12–21 - NCT06254248RecruitingPhase 2
Safety of two cancer drugs after liver transplant
This trial tests a combination of two drugs (atezolizumab and bevacizumab) for people whose liver cancer has returned after a liver transplant and cannot be treated with surgery or other local procedures. The goal is to see if this treatment is safe for liver transplant recipients.
ClichyAges 18–90 - NCT06263153RecruitingPhase 2
Futibatinib and durvalumab before bladder cancer surgery
This trial tests two drugs (futibatinib and durvalumab) given before bladder removal surgery for people with muscle-invasive bladder cancer who cannot take standard cisplatin chemotherapy. The goal is to see if the combination shrinks the tumor and improves outcomes.
Ann Arbor, MichiganAges 18 years+ - NCT06254326RecruitingPhase 1
Immune cell therapy for recurrent oligodendroglioma
This trial tests a personalized immune cell therapy for adults with a specific type of brain tumor (oligodendroglioma) that has come back. The treatment uses your own immune cells to target the tumor.
Gainesville, FloridaAges 18–89 - NCT06258447Recruiting
CardiAMP bone marrow cell therapy for heart failure
This trial tests a new treatment using your own bone marrow cells to help your heart pump better. It's for people with heart failure after a heart attack whose heart function is moderately reduced.
Clearwater, FloridaAges 21–90 - NCT06274515RecruitingPhase 4
Study of resistance to breast cancer therapies
This study looks at why some breast cancers stop responding to treatment. It involves taking a small sample of your tumor (biopsy) and blood to understand resistance. If you have HER2-positive or triple-negative breast cancer that is growing despite treatment, you may be able to join.
AnderlechtAges 18 years+ - NCT06183359Recruiting
Self-Identification Program for Depression
This study tests a self-identification program for people aged 18 to 70 who are currently in a major depressive episode. It aims to explore whether a simple self-monitoring tool can help you better manage your depression.
MontpellierAges 18–70 - NCT03329313RecruitingPhase 2
Adjusting dialysis salt levels for ICU kidney injury
This study tests whether using a specific salt (sodium) level in the dialysis fluid affects outcomes for adults in the ICU with sudden kidney failure. It may help your care team optimize dialysis settings during acute kidney injury.
Montpellier, MontpellierAges 18–80 - NCT05322460Recruiting
Online support program for long-term breast cancer survivors
This study tests a web-based program to support women who have finished breast cancer treatment and have no signs of active disease. It may help improve how you cope, stay informed, and manage life after treatment.
PamplonaAges 18–99 - NCT06247787RecruitingPhase 1
Imetelstat plus chemo for relapsed leukemia in kids
This trial tests a new drug called imetelstat combined with two chemotherapy drugs (fludarabine and cytarabine) for children and teens with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or juvenile myelomonocytic leukemia (JMML) that has come back or not responded to treatment. The goal is to find the safest dose of imetelstat and see if it helps control the cancer.
Birmingham, AlabamaAges 1–18 - NCT06230887Enrolling by invitation
New treatment for moral injury in veterans
This study tests a new therapy for veterans struggling with moral injury—distress from events that go against personal values. It compares two treatment approaches to see which works better.
Little Rock, ArkansasAges 18 years+ - NCT06233942RecruitingPhase 1
Testing a new drug for advanced solid tumors
This early-phase trial tests a new drug called BG-C9074, either alone or with other cancer treatments, for people with certain advanced solid tumors that have not responded to standard therapy. The goal is to see if it is safe and effective.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,177 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.